Testosterone Replacement Therapy (TRT)

Testosterone replacement therapy represents one of the most extensively studied hormone interventions for age-related decline in men. Research indicates TRT can effectively restore testosterone levels in men with clinically diagnosed hypogonadism, with studies suggesting improvements in muscle mass, bone density, sexual function, and quality of life measures. The Testosterone Trials, a large coordinated research effort, demonstrated modest but clinically meaningful benefits in sexual function, physical performance, and mood in older men with low testosterone levels.

However, TRT research has revealed important considerations regarding cardiovascular safety, with some studies suggesting increased risk of heart attack and stroke, while others show neutral or protective effects. Recent large-scale analyses indicate the cardiovascular risk may be lower than initially feared, particularly when therapy is properly monitored and testosterone levels are maintained within physiological ranges. Studies also suggest that TRT does not appear to increase prostate cancer risk in men with normal baseline prostate health, contrary to earlier concerns.

The intervention requires careful medical supervision, including regular monitoring of testosterone levels, hematocrit, prostate markers, and cardiovascular health. Research indicates optimal outcomes occur when treatment is individualized based on symptoms, baseline hormone levels, and patient response, rather than pursuing supraphysiological levels. Different delivery methods show varying efficacy and side effect profiles, with injectable forms generally providing the most consistent blood levels according to pharmacokinetic studies.